Lifecore Biomedical, Inc. ( LFCR) - Key Metrics
LFCR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | ? | ? | ? | ? |
| 2026Q2 | $1.19 | -$0.21 | $0.15 | $0.10 |
| 2026Q1 | $0.83 | -$0.27 | $0.05 | $0 |
| 2025Q4 | $0.98 | -$0.03 | $0.14 | $0.09 |
| 2025Q3 | $0.95 | -$0.40 | $0.03 | -$0.11 |
LFCR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | ? | ? |
| 2026Q2 | ? | -9.61 |
| 2026Q1 | ? | -6.89 |
| 2025Q4 | ? | -54.23 |
| 2025Q3 | ? | -3.51 |
LFCR Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q3 | 2.57% | ? |
| 2026Q2 | 1.18% | ? |
| 2026Q1 | 0.01% | ? |
| 2025Q4 | 1.31% | ? |
| 2025Q3 | -2.05% | ? |
LFCR
Price: $4.62
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.27 USD
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 189.4 million